Roche May Share Trial Data on Avastin Amid Brain Cancer Conflict - Businessweek

[INCIID News Feed]

<img alt="" height="1" width="1" />
Roche May Share Trial Data on Avastin Amid Brain Cancer Conflict
Businessweek
Roche Holding AG (ROG) and a group of outside investigators may share raw data from conflicting trials of Avastin to help determine whether the $7 billion-a-year treatment really helps patients with deadly brain cancer. The data is from two trials that both ...
Avastin prolongs survival in advanced cervical cancerUSA TODAY
No Survival Benefit for Avastin in GlioblastomaMedPage Today
Benefit of Bevacizumab in Glioblastoma Under DiscussionMedscape
Healio -Health.com -The Oncology Report
all 13 news articles &raquo;


More...